Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Maddox

Showing results (321-330 of 427) with videos related to

Pageof 43
Sort By:
The American Journal of Cardiology|December 3, 2014
A national clinical quality program for Veterans Affairs catheterization laboratories (from the Veterans Affairs clinical assessment, reporting, and tracking program)Thomas M Maddox, Mary E Plomondon, Megan Petrich, et al.
Current Urology|June 12, 2014
Nomogram to predict prostate cancer diagnosis on primary transrectal ultrasound-guided prostate biopsy in a contemporary seriesChristopher J DiBlasio, Ithaar H Derweesh, Michael M Maddox, et al.
Circulation. Cardiovascular Quality and Outcomes|May 17, 2017
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS<sub>2</sub> to the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Thromboembolic Risk Assessment: Analysis From the National Cardiovascular Data Registry's Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation RegistryDavid F Katz, Thomas M Maddox, Mintu Turakhia, et al.
JAMA|December 10, 2009
Contraindicated medication use in dialysis patients undergoing percutaneous coronary interventionThomas T Tsai, Thomas M Maddox, Matthew T Roe, et al.
American Heart Journal|June 2, 2015
Variation in performance measure criteria significantly affects cardiology practice rankings: Insights from the National Cardiovascular Data Registry's Practice Innovation and Clinical Excellence RegistryZubin J Eapen, Fengming Tang, Phil G Jones, et al.
American Heart Journal|September 1, 2014
Type of β-blocker use among patients with versus without diabetes after myocardial infarctionSuzanne V Arnold, John A Spertus, Kasia J Lipska, et al.
BMC Cardiovascular Disorders|September 4, 2017
Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administrationRyan T Borne, Colin O'Donnell, Mintu P Turakhia, et al.
The American Journal of Cardiology|November 16, 2019
Implications of Guideline Updates for the Management of Apparent Treatment Resistant Hypertension in the United States (A NCDR Research to Practice [R2P] Project)Anna M Maw, Lauren E Thompson, P Michael Ho, et al.
European Heart Journal|June 22, 2019
Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare populationRachel P Dreyer, Rosanna Tavella, Jeptha P Curtis, et al.
Heart (British Cardiac Society)|March 25, 2015
Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarctionSupriya Shore, Philip G Jones, Thomas M Maddox, et al.
Pageof 43

Showing results (321-330 of 427) with videos related to

Sort By:
Pageof 43
The American Journal of Cardiology|December 3, 2014
A national clinical quality program for Veterans Affairs catheterization laboratories (from the Veterans Affairs clinical assessment, reporting, and tracking program)Thomas M Maddox, Mary E Plomondon, Megan Petrich, et al.
Current Urology|June 12, 2014
Nomogram to predict prostate cancer diagnosis on primary transrectal ultrasound-guided prostate biopsy in a contemporary seriesChristopher J DiBlasio, Ithaar H Derweesh, Michael M Maddox, et al.
Circulation. Cardiovascular Quality and Outcomes|May 17, 2017
Contemporary Trends in Oral Anticoagulant Prescription in Atrial Fibrillation Patients at Low to Moderate Risk of Stroke After Guideline-Recommended Change in Use of the CHADS<sub>2</sub> to the CHA<sub>2</sub>DS<sub>2</sub>-VASc Score for Thromboembolic Risk Assessment: Analysis From the National Cardiovascular Data Registry's Outpatient Practice Innovation and Clinical Excellence Atrial Fibrillation RegistryDavid F Katz, Thomas M Maddox, Mintu Turakhia, et al.
JAMA|December 10, 2009
Contraindicated medication use in dialysis patients undergoing percutaneous coronary interventionThomas T Tsai, Thomas M Maddox, Matthew T Roe, et al.
American Heart Journal|June 2, 2015
Variation in performance measure criteria significantly affects cardiology practice rankings: Insights from the National Cardiovascular Data Registry's Practice Innovation and Clinical Excellence RegistryZubin J Eapen, Fengming Tang, Phil G Jones, et al.
American Heart Journal|September 1, 2014
Type of β-blocker use among patients with versus without diabetes after myocardial infarctionSuzanne V Arnold, John A Spertus, Kasia J Lipska, et al.
BMC Cardiovascular Disorders|September 4, 2017
Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administrationRyan T Borne, Colin O'Donnell, Mintu P Turakhia, et al.
The American Journal of Cardiology|November 16, 2019
Implications of Guideline Updates for the Management of Apparent Treatment Resistant Hypertension in the United States (A NCDR Research to Practice [R2P] Project)Anna M Maw, Lauren E Thompson, P Michael Ho, et al.
European Heart Journal|June 22, 2019
Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a Medicare populationRachel P Dreyer, Rosanna Tavella, Jeptha P Curtis, et al.
Heart (British Cardiac Society)|March 25, 2015
Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarctionSupriya Shore, Philip G Jones, Thomas M Maddox, et al.
Pageof 43